Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 239623, 10 pages
http://dx.doi.org/10.1155/2015/239623
Research Article

CD4+RORγt++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis

1Department of Gastroenterology and Hepatology, Antwerp University Hospital, 2560 Antwerp, Belgium
2Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari, 70100 Bari, Italy
3Laboratory of Experimental Medicine and Paediatrics, Division of Gastroenterology, University of Antwerp, 2560 Antwerp, Belgium
4Laboratory of Pharmacology, University of Antwerp, 2560 Antwerp, Belgium
5Laboratory of Immunology, Allergology and Rheumatology, University of Antwerp, 2560 Antwerp, Belgium
6International Tissue Engineering Research Association (ITERA) Life Sciences Forum, 3620 Lanaken, Belgium
7Genetisch-Diagnostisches Labor, 50939 Köln, Germany

Received 27 February 2015; Revised 7 June 2015; Accepted 14 June 2015

Academic Editor: Jianfei Yang

Copyright © 2015 Luisa Vonghia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Vonghia, P. Michielsen, and S. Francque, “Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19867–19890, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Barbi, D. Pardoll, and F. Pan, “Metabolic control of the Treg/Th17 axis,” Immunological Reviews, vol. 252, no. 1, pp. 52–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Tang, Z. Bian, L. Zhao et al., “Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease,” Clinical and Experimental Immunology, vol. 166, no. 2, pp. 281–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Meng, K. Wang, T. Aoyama et al., “Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice,” Gastroenterology, vol. 143, no. 3, pp. 765–776.e3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Zuniga, W. J. Shen, B. Joyce-Shaikh et al., “IL-17 regulates adipogenesis, glucose homeostasis, and obesity,” The Journal of Immunology, vol. 185, pp. 6947–6959, 2010. View at Google Scholar
  6. S. Winer, Y. Chan, G. Paltser et al., “Normalization of obesity-associated insulin resistance through immunotherapy,” Nature Medicine, vol. 15, no. 8, pp. 921–929, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. H. Oo, S. G. Hubscher, and D. H. Adams, “Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management,” Hepatology International, vol. 4, no. 2, pp. 475–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Ma, J. Hua, A. R. Mohamood, A. R. A. Hamad, R. Ravi, and Z. Li, “A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury,” Hepatology, vol. 46, no. 5, pp. 1519–1529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Söderberg, J. Marmur, K. Eckes et al., “Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis,” APMIS, vol. 119, no. 7, pp. 412–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Feuerer, L. Herrero, D. Cipolletta et al., “Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters,” Nature Medicine, vol. 15, no. 8, pp. 930–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Eller, A. Kirsch, A. M. Wolf et al., “Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy,” Diabetes, vol. 60, no. 11, pp. 2954–2962, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Sun and M. Karin, “Obesity, inflammation, and liver cancer,” Journal of Hepatology, vol. 56, no. 3, pp. 704–713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Polyzos, J. Kountouras, C. Zavos, and G. Deretzi, “The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature,” Journal of Clinical Gastroenterology, vol. 45, no. 1, pp. 50–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Lord, G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler, “Leptin modulates the T-cell immune response and reverses starvation- induced immunosuppression,” Nature, vol. 394, no. 6696, pp. 897–901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Procaccini, E. Jirillo, and G. Matarese, “Leptin as an immunomodulator,” Molecular Aspects of Medicine, vol. 33, no. 1, pp. 35–45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yu, Y. Liu, F.-D. Shi, H. Zou, G. Matarese, and A. La Cava, “Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus,” The Journal of Immunology, vol. 190, no. 7, pp. 3054–3058, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Sumarac-Dumanovic, D. Stevanovic, A. Ljubic et al., “Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women,” International Journal of Obesity, vol. 33, no. 1, pp. 151–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. V. De Rosa, C. Procaccini, G. Calì et al., “A key role of leptin in the control of regulatory T cell proliferation,” Immunity, vol. 26, no. 2, pp. 241–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Gabriely, X. H. Ma, X. M. Yang et al., “Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?” Diabetes, vol. 51, no. 10, pp. 2951–2958, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. K. G. Blom, M. Rahman Qazi, J. B. Noronha Matos, B. D. Nelson, J. W. DePierre, and M. Abedi-Valugerdi, “Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained,” Clinical and Experimental Immunology, vol. 155, no. 2, pp. 320–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. M. Bastiaansen-Jenniskens, S. Clockaerts, C. Feijt et al., “Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage,” Annals of the Rheumatic Diseases, vol. 71, no. 2, pp. 288–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. F. F. Mandy, M. Bergeron, and T. Minkus, “Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: a short history of the development of gating strategies for CD4+ T-cell enumeration,” Cytometry, vol. 30, no. 4, pp. 157–165, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. E. M. Brunt, D. E. Kleiner, L. A. Wilson, P. Belt, and B. A. Neuschwander-Tetri, “Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings,” Hepatology, vol. 53, no. 3, pp. 810–820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, “Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions,” The American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467–2474, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Takahashi, Y. Soejima, and T. Fukusato, “Animal models of nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis,” World Journal of Gastroenterology, vol. 18, no. 19, pp. 2300–2308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Francque, W. Laleman, L. Verbeke et al., “Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture,” Laboratory Investigation, vol. 92, no. 10, pp. 1428–1439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Deiuliis, Z. Shah, N. Shah et al., “Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers,” PLoS ONE, vol. 6, no. 1, Article ID e16376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Wolowczuk, B. Hennart, A. Leloire et al., “Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: An attempt to maintain immune homeostasis and vascular tone,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 303, no. 2, pp. R135–R143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Van Harmelen, S. Reynisdottir, P. Eriksson et al., “Leptin secretion from subcutaneous and visceral adipose tissue in women,” Diabetes, vol. 47, no. 6, pp. 913–917, 1998. View at Google Scholar
  32. M. V. MacHado, J. Coutinho, F. Carepa, A. Costa, H. Proença, and H. Cortez-Pinto, “How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease,” European Journal of Gastroenterology and Hepatology, vol. 24, no. 10, pp. 1166–1172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Loffreda, S. Q. Yang, H. Z. Lin et al., “Leptin regulates proinflammatory immune responses,” The FASEB Journal, vol. 12, no. 1, pp. 57–65, 1998. View at Google Scholar · View at Scopus
  34. M. Asrih and F. R. Jornayvaz, “Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance,” Journal of Endocrinology, vol. 218, no. 3, pp. R25–R36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. D. E. Cintra, J. R. Pauli, E. P. Araújo et al., “Interleukin-10 is a protective factor against diet-induced insulin resistance in liver,” Journal of Hepatology, vol. 48, no. 4, pp. 628–637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. M. dDen Boer, P. J. Voshol, J. P. Schröder-van der Elst et al., “Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice,” Endocrinology, vol. 147, no. 10, pp. 4553–4558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Fujisaka, I. Usui, A. Bukhari et al., “Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice,” Diabetes, vol. 58, no. 11, pp. 2574–2582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. K. H. G. Mills, “Induction, function and regulation of IL-17-producing T cells,” European Journal of Immunology, vol. 38, no. 10, pp. 2636–2649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Mehta, A. M. Nuotio-Antar, and C. W. Smith, “γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice,” Journal of Leukocyte Biology, vol. 97, no. 1, pp. 121–134, 2015. View at Publisher · View at Google Scholar
  40. K. Tajiri and Y. Shimizu, “Role of NKT cells in the pathogenesis of NAFLD,” International Journal of Hepatology, vol. 2012, Article ID 850836, 6 pages, 2012. View at Publisher · View at Google Scholar
  41. J. du Plessis, J. van Pelt, H. Korf et al., “Association of adipose tissue inflammation with histological severity of non-alcoholic fatty liver disease,” Gastroenterology, 2015. View at Publisher · View at Google Scholar